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Aim: Anastomotic leakage after restorative surgery for rectal cancer shows high morbid-
ity and related mortality. Identification of risk factors could change operative planning, 
with indications for stoma construction. This retrospective multicentre study aims to as-
sess the anastomotic leak rate, identify the independent risk factors and develop a clinical 
prediction model to calculate the probability of leakage.
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INTRODUC TION
Anastomotic leakage (AL) represents a frequent and severe com-
plication after resection for rectal cancer (RC), with reported inci-
dence and related mortality ranging from 0.0% to 36.3% and from 
2% to 9%, respectively [1]. Additionally, many AL- related compli-
cations, such as intra- abdominal abscesses, wound infections, dif-
fuse peritonitis and sepsis, can lead to lengthened hospital stay 
(LoS), reoperation, increased mortality and worsened survival out-
comes [2].
In a review by Bruce et al. [3], 56 different definitions of AL were 
documented; several studies have tried to define the characteristics 
of AL and its grades of severity [2,4]. The most recurrent definition 
described AL as ‘a communication between the intraluminal and ex-
traluminal compartments owing to a defect of the integrity of the 
intestinal wall at the anastomosis between the colon and rectum or 
the colon and anus’ [2]. Usually, AL is diagnosed between postoper-
ative days 1 and 14 [1]; however, late leaks, occurring after patient 
discharge or even after the 30th postoperative day, have frequently 
been described [5].
Management of AL is primarily based on the patient's clinical 
stability; treatment can be conservative, with antibiotics associated 
with total parenteral nutrition in the case of subclinical leaks. While 
endoscopic treatment with colonic stenting, clip placement and en-
doluminal vacuum therapy or percutaneous drainage can be per-
formed in stable patients with no signs and symptoms of incoming 
sepsis [6– 8], surgery with abdominal and pelvic revision, together 
with bowel diversion, is mandatory in the case of otherwise un-
manageable abdominal sepsis [9]. Ultimately, AL negatively affects 
patients' overall and disease- specific survival, as well as local recur-
rence [10,11].
Based on the results of univariate and multivariate analysis of 
patient- and procedure- related variables, several independent fac-
tors to predict AL incidence and severity, such as the distance of 
the anastomosis from the anal verge, male sex and obesity [12,13], 
have been identified in recent years. Unfortunately, retrospective 
and other observational studies have several limitations, primarily 
due to their small sample size [4,14].
A recent, large sample size meta- analysis developed a specific 
score to predict the hazard of AL. Notwithstanding, this study also 
included data from secondary care facilities with variations in tech-
nologies and skills, which may have affected AL incidence [15,16].
Considering the lack of accurate assessment of risk factors for AL 
in the literature, the purpose of this study was to estimate the overall 
anastomotic leak rate after restorative resection for RC, identify the 
independent risk factors, and develop a clinical prediction model to 
calculate the probability of AL occurrence.
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Methods: The study used data from 24 Italian referral centres of the Colorectal Cancer 
Network of the Italian Society of Surgical Oncology. Patients were classified into two 
groups, AL (anastomotic leak) or NoAL (no anastomotic leak). The effect of patient- , dis-
ease- , treatment- and postoperative outcome- related factors on anastomotic leak after 
univariable and multivariable analysis was measured.
Results: A total of 5398 patients were included, 552 in group AL and 4846 in group NoAL. 
The overall incidence of leaks was 10.2%, with a mean time interval of 6.8 days. The 
30- day leak- related mortality was 2.6%. Sex, body mass index, tumour location, type 
of approach, number of cartridges employed, weight loss, clinical T stage and combined 
multiorgan resection were identified as independent risk factors. The stoma did not re-
duce the leak rate but significantly decreased leak severity and reoperation rate. A nomo-
gram with a risk score (RALAR score) was developed to predict anastomotic leak risk at 
the end of resection.
Conclusions: While a defunctioning stoma did not affect the leak risk, it significantly re-
duced its severity. Surgeons should recognize independent risk factors for leaks at the 
end of rectal resection and could calculate a risk score to select high- risk patients eligible 
for protective stoma construction.
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What does this paper add to the literature?
This study identified nine independent risk factors for 
colorectal anastomotic leak. The construction of a defunc-
tioning stoma was documented to be a protective factor 
for clinical severity of leaks. A specific score (RALAR score) 
available online can help surgeons to intra- operatively se-
lect patients who may benefit from protective ostomy.
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METHODS
Study design and oversight
This nationwide, multicentre, retrospective study involved 24 Italian 
referral centres for colorectal surgery; the guidelines set out in the 
STROBE statement [17] were followed. Central Ethics Committee 
approval was obtained by the AOU San Luigi Gonzaga human re-
search institutional review board (approval date 23 October 2018, 
protocol number 15525). Individual sites not covered by central ap-
proval obtained the local committee's approval.
All consecutive patients with RC within 15 cm from the anal 
verge, submitted to resection surgery for rectal cancer between January 
2000 and December 2016, were included in the study. Inclusion and 
exclusion criteria are detailed in Table S1. Based on their postoperative 
course, patients were classified into two groups: patients with anasto-
motic leak, AL; or patients without anastomotic leak, NoAL.
Most patients (93.9%) had a minimum follow- up of at least 
5 years.
Study variables, staging procedures and 
preoperative treatments
Patient- , disease- , treatment- and postoperative progress- related 
variables were analysed. Leak- related factors included radiologi-
cal leak rate, clinical leak rate (presence of clinical signs confirmed 
by CT scan), AL severity grading (type A, B and C according to the 
International Study Group of Rectal Cancer [ISGRC] grading [2]), 
early and late leak rate (diagnosis at <20 or >20 postoperative days, 
respectively) and related reoperation rate, morbidity and mortality.
All included patients were submitted to the same staging workup, 
which encompassed endoscopy with biopsy, a carcinoembryonic an-
tigen serum test and a CT scan. Rigid rectoscopy and high- resolution 
MRI or transrectal ultrasound were subsequently administered to as-
sess tumour height (tumours were classified as high, middle or low 
when located 10– 15 cm [upper rectum], 5– 10 cm [middle rectum] or 
<5 cm [low rectum] from the anal verge, respectively) and cT/cN stage.
Weight loss was defined as the loss of 10% or more of body 
weight over the last 6 months.
After a multidisciplinary team evaluation, patients were submit-
ted to neoadjuvant treatment or upfront surgery according to clinical 
tumour stage, following updated oncological guidelines. Emergency 
surgery was defined as an unplanned procedure performed in pa-
tients referred to the Emergency Department due to perforation, 
severe bleeding or bowel obstruction unsuitable for endoscopic 
stenting; planned surgical procedures performed for uncomplicated 
disease at presentation were defined as elective surgery.
Surgical techniques
Surgery following preoperative treatment was performed within 
1– 12 weeks, depending on administration, duration and dose of 
radiotherapy and/or chemotherapy. Three different types of pro-
cedures were initially considered for inclusion in the study: rectal 
anterior resection (RAR), intersphincteric resection and total proc-
tocolectomy. However, after completion of the dataset, patients 
submitted to intersphincteric resection or total proctocolectomy 
were excluded from statistical analysis due to their small number 
compared to that of RAR.
RAR involves resecting the sigmoid or descending colon and rec-
tum and removing the mesorectum (partially or totally), depending 
on tumour location; the anastomosis was made between the remain-
ing colon and the rectum. Each surgeon decided at his own discre-
tion to create a protective stoma at the end of the RAR procedure, 
based on his own criteria of measuring the risk of a leak in each spe-
cific patient.
The type of approach adopted was classified into three groups: 
open surgery, minimally invasive (laparoscopic/robotic) surgery 
(MIS) not converted, and MIS converted.
Clinical staging and pathology
Both clinical and pathological staging were performed according to 
the American Joint Committee on Cancer staging system. We pro-
ceeded to reclassify all cases referring to the the 8th edition of the 
TNM classification [18]. Mandard classification was used to categorize 
the specimen of patients submitted to preoperative treatment [19].
Anastomotic leak diagnosis and grading
Diagnosis was made based on the presence of clinical (pain, fever, 
tachycardia, peritonitis, or feculent, enteric or purulent drainage) 
and radiological (fluid- or gas- containing collections during the 
CT scan or water- soluble contrast enema) signs, as well as intra- 
operative findings (gross enteric spillage or anastomotic disrup-
tion). Subclinical AL diagnosis was based solely on radiological 
signs; ISGRC grading was used to assess AL severity [2]. Briefly, 
ISGCR type A leak corresponds to a radiological leakage which is 
not associated with clinical symptoms and does not require any 
interventional procedure; type B AL is a leakage requiring active 
intervention without the need for reoperation (antibiotics, radio-
logical or endoscopic procedures) and type C ALs are severe leak-
ages requiring reoperation.
Main outcomes and measures
The primary end- point of this study was the detection of any inde-
pendent risk factors for anastomotic leak after anterior resection 
for rectal cancer in a large sample size multicentre retrospective 
study with the aim of developing a new specific risk score (RALAR 
score).
Secondary end- points included the overall rate of AL in the study 
population; the distribution of leaks according to ISGRC clinical 
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severity grading; the relationship between defunctioning - ostomy, leak 
occurrence and leak clinical severity grade; the rate of overall morbid-
ity, 30- day mortality and reoperation in patients with and without AL.
Statistical analysis
Primary analysis was performed by comparing variables between 
groups with and without AL. A secondary analysis assessed AL se-
verity by comparing variables between types A/B and type C anas-
tomotic leaks.
For the primary analysis we performed a series of univariable 
analyses to compare the two groups with respect to demographics, 
clinical and pathological data and postoperative outcomes.
Based on tests of normality, all continuous distributions (i.e., age, 
body mass index [BMI] and LoS) were non- normal and, accordingly, a 
nonparametric Wilcoxon rank- sum test was used to compare median 
values. The chi- squared test with Yates's continuity correction was 
used to compare categorical data across groups.
All eight demographics, clinical, surgical and pathological covari-
ates significantly related to AL (sex, weight loss, number of cartridges, 
type of approach, combined multiorgan resection, operating time, 
cancer location and clinical T stage [cT]) together with BMI (for clinical 
relevance) were selected and multiple imputation on these variables 
was performed (given the high number of missing values in some of 
them) using data from the same set of covariates to handle missing 
data and improve the power of the analysis. Missing data were as-
sumed to be missing at random, and the R mice procedure was used to 
impute the missing data. A total of 20 imputed datasets were created 
to account for sampling variability from the imputation process. For 
each dataset, a backward stepwise procedure was used to identify 
the most relevant variables; following the majority method, we did 
not remove any of the nine variables for the final model because all 
of them appeared in at least half of the models. A pooled multivariate 
logistic regression analysis of the 20 datasets was made to evaluate 
the impact of all the nine risk factors for anastomotic leak.
Predictive accuracy was assessed by averaging in the 20 imputed 
datasets the area under the receiver operating curve, the sensitivity 
and specificity to predict AL risk and the best threshold to maximize 
sensitivity and specificity. A nomogram was created, based on this 
model. All statistical analyses were performed using R version 4.0.5 
(© The R Foundation); statistical significance was set at P < 0.05.
RESULTS
Patient characteristics and perioperative outcomes
Between January 2000 and December 2016, 5398 patients submit-
ted to restorative surgery for RC across 24 Italian referral centres 
with expertise in colorectal resections were entered into this study. 
Half of the hospitals reported more than 30 cases per year during the 
study period. Patients were included in one of two groups based on 
their postoperative progress: AL group (n = 552 patients, 10.2%) and 
NoAL group (n = 4846 patients, 89.8%). Clinical and demographic 
characteristics of the included patients are detailed in Table 1; pa-
tients' median age was 67.1 years (58.7– 74.7), with no significant dif-
ference between the two groups.
Patients who developed AL were significantly more likely to 
be men (P < 0.001), had a higher BMI and experienced greater 
weight loss (P = 0.045). By contrast, the American Society of 
Anesthesiologists score, Charlson Comorbidity Index score and 
smoking/alcohol habits did not correlate with AL.
The surgical approach adopted significantly influenced the inci-
dence of AL (Table 2), and the proportion of AL was higher after 
minimally invasive surgery (P = 0.003).
In univariate analysis, stapled rectal resection using more 
than one cartridge (P < 0.001), combined multiorgan resections 
(P = 0.004) and longer operating times (P < 0.001) were strictly re-
lated to a higher risk of AL (Table 2).
In the same univariate analysis a stoma set- up was not identified 
as an independent protective factor of AL occurrence (P = 0.066) 
(Table 2). Mobilization of the splenic flexure, site of central vascular 
ligation (low vs. high), type of anastomosis and pelvic drain position-
ing were not related to the risk of AL.
However, ALs identified after stapled anastomoses showed more 
severe complications than those observed after manual procedures.
Clinical staging and pathological characteristics
Clinical T stage was recognized as significantly related to AL, while 
cN and cM were not (Table 3).
Tumour distance from the anal verge (and cancer location in 
upper, middle or lower rectum) and (y)pT/(y)pN stages of the disease 
were significantly related to AL. A complete response to neoadju-
vant treatment was identified as not protective for AL (P = 0.379) in 
this study, but the evidence of this result is strongly limited by the 
amount of missing data regarding both neoadjuvant treatment and 
tumour response grade.
Postoperative outcomes
All postoperative complications, including medical complications 
(P = 0.006) and Clavien– Dindo grade ≥3, occurred more frequently 
in the AL than the NoAL group. Consequently, the reoperation rate 
(P < 0.001), LoS (P < 0.001) and 30- day mortality (P < 0.001) were 
also significantly higher in AL patients (Table 4). 30- day postopera-
tive mortality and median LoS were 2.6% versus 0.7% and 19 versus 
9 days in the AL versus NoAL group.
Anastomotic leak
Table 5 details the distribution of AL according to ISGRC grading. 
The overall incidence of AL was 10.2%, and a severe (type C) leak 
was identified in 54% of cases. Most cases occurred before the 
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20th postoperative day, with a mean time interval of 6.8 days. In 
clinically asymptomatic patients with normal laboratory tests (type 
A leak), no treatment was necessary. Endoscopic and radiological 
procedures were the first- line treatments for type B AL; these pa-
tients were frequently submitted to endoscopic stent or clip place-
ment, endoscopic vacuum therapy or percutaneous pelvic drain 
positioning.
Table 6 describes the variation of the distribution of treatment- 
and postoperative progress- related factors in patients with a type 
A/B or a type C leak. The analysis was done in 494 patients, as the 
clinical severity grade was not available for 58 of them (Table 5). 
More than half of patients underwent surgery due to a severe leak 
(type C AL). Reoperation was also performed after non- surgical 
treatment failures (30.6%), mostly in type B AL. The overall 30- day 
TA B L E  1  Patient population
Patient characteristics No AL AL 95% CI Total P
Age Median (IQR) 67.0 (58.8– 74.8) 67.4 (58.3– 74.1) 67.1 (58.7– 74.7) 0.624
Sex Female 1966 (92.3) 164 (7.7) 6.6– 8.9 2130 (100) <0.001
Male 2879 (88.1) 388 (11.9) 10.8– 13 3267 (100)
(Missing) 1 (100.0) 0 (0.0) 1 (100)
BMI Median (IQR) 25.2 (22.9– 27.8) 25.6 (23.3– 28.4) 25.3 (23.0– 27.8) 0.054
CCI 2 2103 (90.6) 218 (9.4) n.a. 2321 (100) 0.602
3 867 (89.8) 99 (10.2) 10.8– 13 966 (100)
4– 5 515 (89.4) 61 (10.6) 8.4– 12.3 576 (100)
6+ 140 (88.1) 19 (11.9) 8.2– 13.4 159 (100)
(Missing) 1221 (88.7) 155 (11.3) 1376 (100)
ASA score I 564 (91.0) 56 (9.0) 9.6– 13.1 620 (100) 0.279
II 1950 (89.0) 242 (11.0) 6.9– 11.6 2192 (100)
III 1068 (88.0) 146 (12.0) 9.8– 12.4 1214 (100)
IV 55 (90.2) 6 (9.8) 10.3– 14 61 (100)
(Missing) 1209 (92.2) 102 (7.8) 1311 (100)
Weight lossa No 2789 (91.0) 276 (9.0) 6.4– 9.4 3065 (100) 0.045
Yes 277 (87.4) 40 (12.6) 8– 10.1 317 (100)
(Missing) 1780 (88.3) 236 (11.7) 2016 (100)
Smoking habits No 2395 (90.5) 250 (9.5) 10.3– 13.2 2645 (100) 0.290
Yes 903 (89.3) 108 (10.7) 8.4– 10.6 1011 (100)
(Missing) 1548 (88.9) 194 (11.1) 1742 (100)
Alcohol habits No 3008 (90.3) 324 (9.7) 9.7– 12.7 3332 (100) 0.724
Yes 254 (89.4) 30 (10.6) 8.7– 10.8 284 (100)
(Missing) 1584 (88.9) 198 (11.1) 1782 (100)
Perioperative 
treatment
No 1216 (90.7) 124 (9.3) 1340 (100) 0.851
Short- course RT 113 (92.6) 9 (7.4) n.a. 122 (100)
Long- course RT 146 (91.2) 14 (8.8) n.a. 160 (100)
Short- course RT + CT 189 (89.2) 23 (10.8) 7.8– 10.9 212 (100)
Long- course RT + CT 1394 (89.9) 156 (10.1) 3.4– 13.5 1550 (100)
CT 377 (91.1) 37 (8.9) 4.9– 14.3 414 (100)
(Missing) 1411 (88.2) 189 (11.8) 1600 (100)
Neoadjuvant 
treatment
No 1216 (90.7) 124 (9.3) 8.6– 11.7 1340 (100) 0.680
Yes 2219 (90.3) 239 (9.7) 6.4– 12.1 2458 (100)
(Missing) 1411 (88.2) 189 (11.8) 1600 (100)
Bold indicated significance value (P < 0.05).
Abbreviations: AL, anastomotic leak; ASA, American Society of Anesthesiologists; BMI, body mass index; CCI, Charlson Comorbidity Index; CT, 
chemotherapy; IQR, interquartile range; RT, radiation therapy.
aWeight loss: reduction of more than 10% of body weight within the last 6 months.
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TA B L E  2  Treatment- related variables
No AL AL 95% CI Total P
No. procedures/year <10 18 (78.3) 5 (21.7) 7.5– 43.7 23 (100) 0.296
10– 19 397 (89.0) 49 (11.0) 8.6– 11 446 (100)
20– 29 543 (89.8) 62 (10.2) 10.3– 13.5 605 (100)
30+ 3888 (89.9) 436 (10.1) 7.8– 10.9 4324 (100)
Emergency surgery No 4630 (89.8) 526 (10.2) 8.2– 14.3 5156 (100) 0.734
Yes 82 (88.2) 11 (11.8) 8– 12.9 93 (100)
(Missing) 134 (89.9) 15 (10.1) 149 (100)
Number of cartridges 1 1651 (92.0) 143 (8.0) 9.4– 11.1 1794 (100) <0.001
>1 1108 (87.7) 155 (12.3) 6.1– 20.2 1263 (100)
(Missing) 2087 (89.1) 254 (10.9) 2341 (100)
Type of approach Open surgery 2222 (91.1) 218 (8.9) 6.8– 9.3 2440 (100) 0.003
MIS not converted 2232 (88.9) 280 (11.1) 10.5– 14.2 2512 (100)
MIS converted 191 (85.3) 33 (14.7) 9.6– 12.2 224 (100)
(Missing) 201 (90.5) 21 (9.5) 222 (100)
Type of procedure Down to up 4660 (89.8) 530 (10.2) 9.9– 12.4 5190 (100) 0.883
Up to down 182 (89.2) 22 (10.8) 10.4– 20.1 204 (100)
(Missing) 4 (100.0) 0 (0.0) 4 (100)
Splenic flexure mobilization No 955 (91.2) 92 (8.8) 6.9– 15.9 1047 (100) 0.273
Yes 3482 (90.0) 386 (10.0) 9.4– 11.1 3868 (100)
(Missing) 409 (84.7) 74 (15.3) 483 (100)
Site of vascular ligation High tie 3922 (90.2) 424 (9.8) 7.1– 10.7 4346 (100) 0.454
Low tie 605 (91.3) 58 (8.7) 9.1– 11 663 (100)
(Missing) 319 (82.0) 70 (18.0) 389 (100)
Type of anastomosis End to end 4260 (89.5) 501 (10.5) 8.9– 10.7 4761 (100) 0.101
Side to end 554 (91.7) 50 (8.3) 6.7– 11.2 604 (100)
(Missing) 32 (97.0) 1 (3.0) 33 (100)
Type of anastomosis Mechanical 4670 (89.8) 529 (10.2) 9.7– 11.4 5199 (100) 0.526
Manual 163 (88.1) 22 (11.9) 6.2– 10.8 185 (100)
(Missing) 13 (92.9) 1 (7.1) 14 (100)
Protective - ostomy No 2219 (89.3) 267 (10.7) 9.4– 11 2486 (100) 0.066
Ileostomy 1976 (90.6) 206 (9.4) 7.6– 17.5 2182 (100)
Colostomy 400 (87.1) 59 (12.9) 0.2– 33.9 459 (100)
(Missing) 251 (92.6) 20 (7.4) 271 (100)
Combined multiorgan 
resection
No 3767 (90.8) 380 (9.2) 8.3– 10.8 4147 (100) 0.004
Yes 788 (87.7) 111 (12.3) 9.9– 16.3 899 (100)
(Missing) 291 (82.7) 61 (17.3) 352 (100)
Operative time (h) <3 h 00 992 (92.3) 83 (7.7) 6.2– 9.5 1075 (100) <0.001
3 h 00– 4 h 59 2252 (89.8) 255 (10.2) 9.0– 11.4 2507 (100)
5 h 00+ 1052 (85.5) 178 (14.5) 12.6– 16.6 1230 (100)
(Missing) 550 (93.9) 36 (6.1) 586 (100)
Pelvic drain No 71 (91.0) 7 (9.0) 7.4– 10 78 (100) 0.978
Yes 4486 (90.3) 483 (9.7) 10.9– 13.3 4969 (100)
(Missing) 289 (82.3) 62 (17.7) 351 (100)
Bold indicated significance value (P < 0.05).
Abbreviations: AL, anastomotic leak; MIS, minimally invasive surgery.
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leak- related mortality was 2.6%, mainly due to grade C AL (92.9%). 
Postoperative mortality of type C leak was 5.2%, which was more 
than 7- fold higher than that of patients without AL (0.7%).
Although a defunctioning stoma did not reduce the risk of leak 
occurrence, it significantly decreased leak severity (P < 0.001), en-
abled conservative treatment in most cases and allowed for quicker 
stoma reversal.
Multivariable analysis and nomogram
The pooled multivariable analysis of risk factors for AL is reported 
in Table 7. Body mass index, sex (male), tumour location (middle and 
low vs. high), type of approach (MIS vs. open), number of cartridges 
employed (1 vs. >1), weight loss, clinical T and combined multiorgan 
resection were identified as independent risk factors in a pooled set 
TA B L E  3  Clinical staging and pathological data
No AL AL 95% CI Total P
Tumour distance from the 
AV (cm)
Median (IQR) 9.0 (6.0– 12.0) 8.0 (5.0– 11.0) 9.0 (6.0– 12.0) 0.042
Cancer location (anatomical 
subdivision)
Upper rectum 1482 (91.5) 137 (8.5) 3.7– 17.6 1619 (100) 0.004
Middle rectum 2153 (89.1) 263 (10.9) 8.9– 11.6 2416 (100)
Lower rectum 984 (87.8) 137 (12.2) 13.8– 22.1 1121 (100)
(Missing) 227 (93.8) 15 (6.2) 242 (100)
cT cT0– 1– 2 1146 (92.2) 97 (7.8) 1243 0.043
cT3– 4 2161 (90.2) 236 (9.8) 2397
(Missing) 1539 (87.5) 219 (12.5) 1758
cN cN0 1880 (92.2) 159 (7.8) 2039 0.166
cN1 499 (89.9) 56 (10.1) 555
cN2 154 (93.3) 11 (6.7) 165
(Missing) 2313 (87.6) 326 (12.4) 2639
cM cM0 3299 (91.1) 321 (8.9) 3620 0.750
cM1 136 (91.9) 12 (8.1) 148
(y)pT stage In situ 85 (94.4) 5 (5.6) 9.7– 12.2 90 (100) <0.001
0 388 (91.5) 36 (8.5) 10.4– 14.3 424 (100)
1 560 (93.6) 38 (6.4) 3.5– 10 598 (100)
2 1190 (90.8) 121 (9.2) 6– 11.6 1311 (100)
3 2210 (88.5) 286 (11.5) 4.5– 8.6 2496 (100)
4 302 (85.6) 51 (14.4) 7.7– 10.9 353 (100)
(Missing) 111 (88.1) 15 (11.9) 126 (100)
(y)pN stage 0 3100 (91.0) 307 (9.0) 11– 18.6 3407 (100) <0.001
1 1047 (88.4) 138 (11.6) 1.8– 12.5 1185 (100)
2 612 (86.2) 98 (13.8) 6.8– 18.9 710 (100)
(Missing) 87 (90.6) 9 (9.4) 96 (100)
pM stage 0 4210 (89.9) 475 (10.1) 9.9– 13.6 4685 (100) 0.371
1 470 (88.5) 61 (11.5) 11.4– 16.6 531 (100)
(Missing) 166 (91.2) 16 (8.8) 182 (100)
R grade 0 4279 (90.5) 449 (9.5) 9.3– 11 4728 (100) 0.708
1 82 (89.1) 10 (10.9) 8.9– 14.5 92 (100)
2 143 (88.8) 18 (11.2) 5.1– 13.9 161 (100)
(Missing) 342 (82.0) 75 (18.0) 417 (100)
Mandard TRG No. Median (IQR) 3.0 (2.0– 4.0) 3.0 (2.0– 4.0) 3.0 (2.0– 4.0) 0.379
(Missing) 3355 (89.8) 382 (10.2) 3737 (100)
Bold indicated significance value (P < 0.05).
Abbreviations: (y)pN, pathological N stage according to the 8th edition of the TNM classification after neoadjuvant treatment (Y) when administered; 
(y)pT, pathological T stage according to the 8th edition of the TNM classification after neoadjuvant treatment (Y) when administered; AL, anastomotic 
leak; AV, anal verge; IQR, interquartile range; pM, pathological M stage according to the 8th edition of the TNM classification; R grade, residual tumour 
classification (R0 corresponds to resection for cure or complete remission; R1 to microscopic residual tumour and R2 to macroscopic residual tumour).
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of 20 logistic regression models with anastomotic leak as dependent 
variable. The average area under the receiver operating curve calcu-
lated on the 20 datasets was 0.617 (95% CI 0.615– 0.619). With an 
average threshold value corresponding to 0.1030 (95% CI 0.1027– 
0.1033), average sensitivity and specificity of the model's probability 
to identify anastomotic leak were 57.8% (95% CI 57.4%– 58.1%) and 
57.8% (95% CI 57.5%– 58.1%) respectively.
To predict AL occurrence, we created a digital nomogram includ-
ing all these covariates significantly correlated with the occurrence 
of a postoperative leak; based on this nomogram, a specific risk score 
(RALAR score) is now available online (http://www.maria notom atis.
it/RALAR score) and could help surgeons in decision- making con-
cerning the creation of a protective stoma.
DISCUSSION
The present study showed an AL incidence of 10.2%, consistent 
with currently published data; conversely, the AL- related mortality 
of 2.6% is much lower than that reported in the literature, primarily 
because patients were treated in referral centres with adequate skill 
and experience also for management of complications.
Risk assessment of AL is crucial for early decision- making; thus, 
several preoperative and intra- operative factors should be consid-
ered: male sex, greater BMI, locally advanced tumour, lymph- node 
metastases and tumour proximity to the anal verge were identified 
as preoperative independent risk factors in this study, together with 
the minimally invasive approach, a longer operating time, the number 
of cartridges employed during a stapled procedure, and a combined 
multivisceral resection. To our knowledge, male sex is significantly 
related to increased AL risk, probably due to the narrower male pel-
vis, as well as androgens that may affect the bowel microcirculation 
acting on intestinal endothelial function [20,21].
Greater BMI and weight loss are both modifiable, independent 
risk factors for AL. Nevertheless, while patients with severe slim-
ming could benefit from preoperative nutritional improvement, rapid 
weight loss in obese patients could further increase the risk of leak, 
as consequent malnutrition significantly affects tissue healing [22].
Consistent with previous data, we observed that the risk of AL 
rises in advanced stage cancer (both in clinical and pathological 
T3– 4 stage) with metastatic nodes. This may be explained by the 
more technical complexity of such cases [1].
Neoadjuvant treatment was not found to be associated with AL 
in this study; while some authors showed a relationship between 
preoperative chemotherapy and AL occurrence, several others 
TA B L E  4  Postoperative outcomes
No AL AL Total P
Medical complication No 3946 (90.0) 439 (10.0) 4385 (100) 0.006
Yes 630 (86.5) 98 (13.5) 728 (100)
(Missing) 270 (94.7) 15 (5.3) 285 (100)
Surg compl CD I– II 333 140 473 <0.001
Surg compl CD III+ 156 360 516
Missing 41 52 93
Reoperation No 3883 (95.4) [97.0]* 189 (4.6) [37.0]* 4072 (100) <0.001
Yes 123 (27.6) [3.0]* 323 (72.4) [63.0]* 446 (100)
(Missing) 840 (95.5) 40 (4.5) 880 (100)
30- day mortality No 3453 (86.7) [99.3]* 531 (13.3) [97.4]* 3984 (100) <0.001
Yes 26 (65.0) [0.7]* 14 (35.0) [2.6]* 40 (100)
(Missing) 1367 (99.5) 7 (0.5) 1374 (100)
Length of stay (days) Median (IQR) 9.0 (7.0– 11.0) 19.0 (12.0– 27.0) 9.0 (7.0– 12.0) <0.001
Bold indicated significance value (P < 0.05).
Abbreviations: AL, anastomotic leak; CD, Clavien– Dindo classification; IQR, interquartile range; Surg compl, surgical complication.
*indicates that the percentage in brackets is referred to the population of the column.
TA B L E  5  Anastomotic leak grade
N % N
Total 5398 100 5398
No AL 4846 89.8 4846
Total AL 552 10.2 552
AL grade Aa 91 1.7 (18.5)b 494
AL grade Ba 136 2.5 (27.5)b
AL grade Ca 267 5.0 (54.0)b
AL grade missing 58 (10.5)b 58
Abbreviation: AL, anastomotic leak.
aAL severity grade: grade according to the International Study Group of 
Rectal Cancer scoring system.
bPercentages referred to the group of patients with AL and severity 
grade available (total number of patients 494).
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could not confirm this bond [23,24]. Still, there are many controver-
sial papers regarding the role of neoadjuvant radiotherapy on AL 
incidence. In the early 1970s, Schrock et al. [25] documented a sub-
stantial increase in AL after radiotherapy. Recently, Arezzo et al. [1] 
separately analysed the effect of short- and long- course radiother-
apy on AL, only showing a significant association with short- course 
treatment; however, the Dutch TME trial, which randomly allocated 
patients with RC in preoperative radiotherapy or in upfront sur-
gery, concluded that the AL rate was not different between the two 
groups [26]. Unfortunately, due to the high number of missing values 
concerning neoadjuvant treatment and tumour response grade, any 
relationships between these factors and the risk of AL are not sup-
ported by sufficient evidence in this study.
An additionally identified independent risk factor for AL is tu-
mour distance from the anal verge, consistent with literature evi-
dence. In the 1990s, Rullier et al. reported a 6.5- fold increased risk 
in anastomoses located <5 cm from the anal verge; similarly, Vignali 
et al. documented a 7- fold increased leak rate risk after low rectal 
stapling [27,28].
In the last few decades, more patients with low- and mid- RC 
have undergone sphincter- saving procedures due to the advent of 
circular stapling devices. Recently, a Cochrane review comparing 
stapling and handsewing in colorectal anastomosis concluded that 
‘the evidence found was insufficient to demonstrate any superiority 
of stapled over handsewn techniques in colorectal anastomosis sur-
gery, regardless of the level of anastomosis’ [29]. This observation is 
in line with the results of our retrospective study; indeed, a higher 
number of grade C leakages were reported after stapled anastomo-
ses and the open approach resulted in a protective independent fac-
tor for AL in this study.
The present study does not show significant differences in AL 
rates among centres with different case volumes, despite the wide 
range reported (2.4%– 24%). Several authors have stated that surgi-
cal experience directly affects leak rate, and that high case volume 
facilities achieve better postoperative outcomes [30,31]. In contrast, 
no significant differences in AL rates between high and low case 
volume centres have been reported. Sørensen et al. documented 
an even lower incidence of AL after resections performed by sur-
geons in training compared with skilled colleagues, as training starts 
with easier cases [32]. Likewise, in the present study, surgeons from 
referral centres were mostly faced with more complex cases, com-
pared with surgeons from low case volume facilities (Table S2).
AL characteristics AL A/B AL C Total P
Total 227 (46.0) 267 (54.0) 494 (100)
Medical 
complication
No 182 (46.3) 211 (53.7) 393 (100) 1.000
Yes 40 (46.0) 47 (54.0) 87 (100)
(Missing) 5 (35.7) 9 (64.3) 14 (100)
Clavien– Dindo 
grade
I– II 130 (96.3) 5 (3.7) 135 (100) <0.001
III+ 93 (26.3) 261 (73.7) 354 (100)
(Missing) 4 (80.0) 1 (20.0) 5 (100)
Protective 
- ostomy
No 80 (32.5) 166 (67.5) 246 (100) <0.001
Ileostomy 121 (61.1) 77 (38.9) 198 (100)
Colostomy 16 (50.0) 16 (50.0) 32 (100)
(Missing) 10 (55.6) 8 (44.4) 18 (100)
Reoperation for 
leak
No 161 (94.2) 10 (5.8) 171 (100) <0.001
Yes 50 (16.4) 255 (83.6) 305 (100)
(Missing) 16 (88.9) 2 (11.1) 18 (100)
30- day mortality No 225 (47.3) 251 (52.7) 476 (100) 0.007
Yes 1 (7.1) 13 (92.9) 14 (100)





113 (46.3) 131 (53.7) 244 (100) 0.005
Late (>20 days) 40 (67.8) 19 (32.2) 59 (100)
(Missing) 74 (38.7) 117 (61.3) 191 (100)
Bold indicated significance value (P < 0.05).
Abbreviations: AL, anastomotic leak; AL A/B, type A and B ALs, according to the International 
Study Group of Rectal Cancer grading; AL C, type C according to the International Study Group of 
Rectal Cancer grading.
TA B L E  6  Anastomotic leak 
characteristics
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To date, even though the minimally invasive approach for RC is 
quickly spreading worldwide, the non- inferiority of laparoscopy com-
pared with open surgery with respect to postoperative complications 
and oncological outcomes is still debated [33– 37]. In the present 
study, the minimally invasive approach was significantly related to 
AL occurrence. Nevertheless, this study enrolled patients over a long 
time period (2000– 2016). In the early 2000s, many surgeons were 
still at the beginning of their learning curves; the available devices 
were archaic, and techniques were not well standardized.
The duration of the procedure, combined multiorgan resections, 
and number of stapling cartridges ≥2 significantly influenced AL 
appearance. These intra- operative risk factors often characterize a 
challenging surgery for locally advanced diseases, or an otherwise 
poor- quality surgery performed by unskilled surgeons. Several au-
thors showed that multiple applications of linear stapler cartridges 
increased the leak risk due to the unduly long stapling line, with 
an oblique angle in the lower location [38,39]. Unfortunately, it is 
commonly believed that several linear staplers are required in male 
patients with a low tumour and narrow pelvis. Indeed, in 2009 Kim 
et al. stated that ‘a diverting ileostomy is mandatory in patients with 
middle and lower RC where multiple linear staplers were used’ [38].
Consistent with data previously reported in the literature 
[40,41], further analyses in this study documented that the use of 
pelvic drainage was not protective against the incidence of AL, nor 
for avoiding consequent reoperation.
Based on the results from this large sample sized study, we gen-
erated a specific score to predict the risk of AL at the end of surgery, 
in time to decide whether to create a diverting stoma. Despite risk 
prediction not providing a tangible mode of prevention, the indica-
tion to construct a stoma can significantly reduce the dehiscence se-
verity, avoid consequent reoperations, and reduce related morbidity 
and mortality. In 1983, Graffner et al. demonstrated that AL after re-
storative surgery for RC may appear in a high percentage of patients 
who had undergone a protective colostomy [42]. Consistent with 
this report and data from the literature, our findings showed that a 
protective stoma did not reduce AL rate significantly; however, leak 
grade, reoperation rate and related 30- day mortality were signifi-
cantly lowered. Nonetheless, while stoma creation could counter-
act dehiscence severity, it may cause patient discomfort and clinical 
problems, have a major effect on overall healthcare costs and may 
even become permanent in some cases. Considering the high rates 
of defunctioning stomas reported during rectal surgery, a warning 
from Austria suggests a benchmark of 10% or less for protective sto-
mas, to limit the overall costs to €12 000 per patient treated [43].
Nevertheless, we believe that surgeons should consider these 
independent risk factors during restorative surgery for RC to even-
tually create a diverting stoma, and strictly follow the patient's 
postoperative course. Finally, surgeons could take advantage of the 
RALAR score (available online at http://www.maria notom atis.it/
RALAR score) which can be used in operating rooms at the end of 
primary resections to determine the leak risk with more precision, as 
well as to decide whether to create a protective stoma.
This study has several limitations due to its retrospective de-
sign and relatively long accrual period. Several issues had important 
missing data, with a consequent lack of details. Moreover, this long 
accrual interval is characterized by many changes concerning periop-
erative treatment, surgical technique, new devices for minimally 
invasive approaches, and conservative management of postopera-
tive complications. Notwithstanding, the RALAR study represents 
a large sample of Italian referral centres (the largest ever published) 
with expertise in RC treatment and can thus serve as an important 
benchmark for further trials.
CONCLUSIONS
Anastomotic leak after restorative RC surgery is a fearsome com-
plication with considerable morbidity and related mortality also in 
Variable analysed OR 95% CI P value
BMI 1.02 0.99– 1.05 0.182
Sex (vs. female) Male 1.55 1.27– 1.88 <0.001
Weight loss Yes 1.26 0.91– 1.75 0.165
cT3– T4 (vs. cT0– 1– 2) Yes 1.17 0.92– 1.48 0.194
Location (vs. low) Middle 0.87 0.69– 1.09 0.218
High 0.68 0.52– 0.87 0.003
Approach (vs. open) MIS not converted 1.26 1.02– 1.56 0.030
MIS converted 1.53 1.02– 2.28 0.039
Number of cartridges (vs. 1) >1 1.26 1.00– 1.59 0.055
Operative time (vs. <3 h) 3 h 00– 4 h 59 1.18 0.91– 1.54 0.210
5 h 00+ 1.54 1.15– 2.04 0.003
Combined multiorgan 
resection
Yes 1.36 1.07– 1.73 0.011
Abbreviations: BMI, body mass index; cT, clinical T stage according to the 8th edition of the TNM 
classification; MIS, minimally invasive surgery; Weight loss, loss of 10% or more of body weight 
over the last 6 months.
TA B L E  7  Multivariable analysis
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large volume referral centres. Although the construction of a pro-
tective - ostomy does not significantly reduce the risk of leak, its se-
verity, need for reoperation and related mortality seem significantly 
decreased. Surgeons should therefore properly recognize the pre-
operative and intra- operative risk factors related to AL and with the 
help of a specific nomogram and risk score (RALAR score) they could 
immediately identify high- risk patients who may benefit from the 
construction of a protective stoma.
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